InflaRx N.V.
IFRXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for IFRX. That does not mean none is planned.
Get an email about IFRX's next catalysts
Track InflaRx (IFRX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
IFRX Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.07 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
IFX-1 + BSC
Severe COVID-19 Pneumonia
BSC
Severe COVID-19 Pneumonia
IFX-1 + SOC
Severe COVID-19 Pneumonia
CaCP29
Severe Sepsis
IFX-1
Hidradenitis Suppurativa
paridiprubart
Acute Respiratory Distress Syndrome (ARDS)
vilobelimab
Pyoderma Gangrenosum
Glucocorticoid (GC)
Granulomatosis With Polyangiitis (GPA)
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
IFX-1 + BSC | Phase 3 | Severe COVID-19 Pneumonia | - | - |
BSC | Phase 3 | Severe COVID-19 Pneumonia | - | - |
IFX-1 + SOC | Phase 3 | Severe COVID-19 Pneumonia | - | - |
CaCP29 | Phase 2 | Severe Sepsis | - | - |
IFX-1 | Phase 2 | Hidradenitis Suppurativa | - | - |
paridiprubart | Phase 2 | Acute Respiratory Distress Syndrome (ARDS) | - | - |
vilobelimab | Phase 2 | Pyoderma Gangrenosum | - | - |
Glucocorticoid (GC) | Phase 2 | Granulomatosis With Polyangiitis (GPA) | - | - |
Frequently asked questions
What is in InflaRx N.V.'s drug pipeline?→
CatalystAlert tracks 8 drug candidates in InflaRx N.V.'s (IFRX) pipeline across Phase 3, Phase 2. Its lead program is BSC (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is InflaRx N.V.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for InflaRx N.V. (IFRX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track IFRX biotech catalysts?→
Add IFRX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow InflaRx N.V.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.